CTLA4 and cancer: Cancer immunotherapy has revolutionized cancer treatment both as monotherapy or in combination strategies, especially ICIs that block cytotoxic T lymphocyte‐associated protein‐4 (CTLA‐4) and the PD‐1/PD‐L1 axis.39, 40